Patents by Inventor Brian Dean Schreiber

Brian Dean Schreiber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATING OR AMELIORATING FIBROSIS, SYSTEMIC SCLEROSIS, SCLERODERMA AND GRAFT VERSUS HOST DISEASE
    Publication number: 20190365874
    Abstract: Provided are Adenosine Deaminase (ADA), or a polypeptides or peptides having an ADA activity, or an ADA conjugate, pharmaceutical compositions and formulations, products of manufacture and kits, and methods containing them for the prevention and treatment of a scleroderma-associated vasculopathy, in particular proliferative obliterative vasculopathy, progressive obliterative vasculopathy or an idiopathic obliterative vasculopathy and/or preventing or decreasing the progression of scleroderma, wherein optionally the scleroderma comprises a local scleroderma or a diffuse, or a systemic scleroderma.
    Type: Application
    Filed: June 21, 2019
    Publication date: December 5, 2019
    Inventors: Brian Dean Schreiber, Gianfranco Fornasini, Nadejda Soukhareva, Santosh Kumar Ramamurthy
  • Compositions and methods for treating or ameliorating fibrosis, systemic sclerosis and scleroderma
    Patent number: 10391154
    Abstract: Provided are Adenosine Deaminase (ADA), or a polypeptides or peptides having an ADA activity, or an ADA conjugate, pharmaceutical compositions and formulations, products of manufacture and kits, and methods containing them for the prevention and treatment of a scleroderma-associated vasculopathy, in particular proliferative obliterative vasculopathy, progressive obliterative vasculopathy or an idiopathic obliterative vasculopathy and/or preventing or decreasing the progression of scleroderma, wherein optionally the scleroderma comprises a local scleroderma or a diffuse, or a systemic scleroderma.
    Type: Grant
    Filed: July 17, 2018
    Date of Patent: August 27, 2019
    Assignee: LEADIANT BIOSCIENCES LTD.
    Inventors: Brian Dean Schreiber, Gianfranco Fornasini, Nadejda Soukhareva, Santosh Kumar Ramamurthy
  • COMPOSITIONS AND METHODS FOR TREATING OR AMELIORATING FIBROSIS, SYSTEMIC SCLEROSIS AND SCLERODERMA
    Publication number: 20190022196
    Abstract: Provided are Adenosine Deaminase (ADA), or a polypeptides or peptides having an ADA activity, or an ADA conjugate, pharmaceutical compositions and formulations, products of manufacture and kits, and methods containing them for the prevention and treatment of a scleroderma-associated vasculopathy, in particular proliferative obliterative vasculopathy, progressive obliterative vasculopathy or an idiopathic obliterative vasculopathy and/or preventing or decreasing the progression of scleroderma, wherein optionally the scleroderma comprises a local scleroderma or a diffuse, or a systemic scleroderma.
    Type: Application
    Filed: July 17, 2018
    Publication date: January 24, 2019
    Inventors: Brian Dean Schreiber, Gianfranco Fornasini, Nadejda Soukhareva, Santosh Kumar Ramamurthy